Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178204 · ClinicalTrials.gov registry record
Sleep Architecture and Chemotherapy-Related Fatigue
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 26
- Enrollment target
NCT00178204 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 26 participants.
The verdict
NCT00178204 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to identify specific chemotherapy-related changes in sleep stages/architecture that may relate to an increase in fatigue in individuals with cancer. The researchers hypothesize that the fatigue experienced by cancer patients receiving chemotherapy is in part due to changes in restorative sleeping during the non-rapid eye movement cycles of sleep (i.e., delta activity).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2004-11 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178204
The ClinicalTrials.gov registry entry for NCT00178204 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00178204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00178204 about?
NCT00178204 is a clinical study titled "Sleep Architecture and Chemotherapy-Related Fatigue". The purpose of this study is to identify specific chemotherapy-related changes in sleep stages/architecture that may relate to an increase in fatigue in individuals with cancer. The researchers hypothesize that the fatigue experienced by cancer patients receiving chemotherapy is in part due to chan...
What is the current status of trial NCT00178204?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2004-11. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT00178204?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.